BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
US Army
Argus Health
US Department of Justice
Cantor Fitzgerald

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020122

« Back to Dashboard

NDA 020122 describes NIPENT, which is a drug marketed by Hospira Inc and is included in one NDA. It is available from one supplier. Additional details are available on the NIPENT profile page.

The generic ingredient in NIPENT is pentostatin. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the pentostatin profile page.

Summary for 020122

Formulation / Manufacturing:see details

Pharmacology for NDA: 020122

Medical Subject Heading (MeSH) Categories for 020122

Suppliers and Packaging for NDA: 020122

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NIPENT pentostatin INJECTABLE;INJECTION 020122 NDA Hospira, Inc. 0409-0801 0409-0801-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0801-01) > 5 mL in 1 VIAL, SINGLE-DOSE

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/VIAL
Approval Date:Oct 11, 1991TE:APRLD:Yes

Expired Orange Book Patents for NDA: 020122

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hospira IncNIPENTpentostatinINJECTABLE;INJECTION020122-001Oct 11, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Chinese Patent Office
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: